Difficulty: Medium
Average Score: 66%
Practice
Low molecular weight heparin (LMWH) prophylaxis to prevent deep vein thrombosis/pulmonary embolism in major surgery:
Correct answer
c
Rationale
The correct answer is C) Is more likely to be of value in an obese man of 50 than in a slim man of 30.
LMWH prophylaxis is used to prevent deep vein thrombosis/pulmonary embolism in high-risk surgical patients. In this context, an obese man of 50 is more likely to benefit from LMWH prophylaxis compared to a slim man of 30 due to the higher risk of thrombotic events associated with obesity and older age.
Option A) Must be started one week before surgery is incorrect because LMWH prophylaxis is usually initiated preoperatively, but the timing may vary based on the specific surgery and patient factors.
Option B) Is via twice-daily intramuscular injection is incorrect because LMWH is typically administered subcutaneously, not intramuscularly, and the frequency of administration can vary.
Option D) Concomitant antibiotics are contraindicated is incorrect because there is no contraindication for using LMWH prophylaxis with antibiotics.
Educationally, understanding the rationale behind the choice of LMWH prophylaxis in different patient populations is crucial for healthcare providers involved in the care of surgical patients at risk for thrombotic events. It highlights the importance of individualized risk assessment and prophylactic measures based on patient demographics and clinical factors.
LMWH prophylaxis is used to prevent deep vein thrombosis/pulmonary embolism in high-risk surgical patients. In this context, an obese man of 50 is more likely to benefit from LMWH prophylaxis compared to a slim man of 30 due to the higher risk of thrombotic events associated with obesity and older age.
Option A) Must be started one week before surgery is incorrect because LMWH prophylaxis is usually initiated preoperatively, but the timing may vary based on the specific surgery and patient factors.
Option B) Is via twice-daily intramuscular injection is incorrect because LMWH is typically administered subcutaneously, not intramuscularly, and the frequency of administration can vary.
Option D) Concomitant antibiotics are contraindicated is incorrect because there is no contraindication for using LMWH prophylaxis with antibiotics.
Educationally, understanding the rationale behind the choice of LMWH prophylaxis in different patient populations is crucial for healthcare providers involved in the care of surgical patients at risk for thrombotic events. It highlights the importance of individualized risk assessment and prophylactic measures based on patient demographics and clinical factors.